HEARTBEAM, INC. Accretion Expense
HEARTBEAM, INC. (BEAT) reported Accretion Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-03-16
- HEARTBEAM, INC. accretion expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- HEARTBEAM, INC. accretion expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- HEARTBEAM, INC. accretion expense for the quarter ending 2021-12-31 was $699.00K.
- HEARTBEAM, INC. accretion expense for the quarter ending 2021-09-30 was $656.00K.
- HEARTBEAM, INC. accretion expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HEARTBEAM, INC. accretion expense for fiscal 2021 was $1.89M.
- HEARTBEAM, INC. accretion expense for fiscal 2020 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $699.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.35M derived: sum of 2 quarters · filed 2023-03-16 | $1.89M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.19M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $531.00K 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |